2m 2m 2m 2m 2m 2m 2m
SPERO THERAPETCS (SPRO)
NASDAQ
$1.80-$0.39 (-17.66%)
Price as of Jul 14, 2026 2:06 PM EDT- $126.2MMarket Cap
- -17.42%1-Year Change
- BiotechnologyIndustry
SPERO THERAPETCS (SPRO)
$1.80-$0.39 (-17.66%)
SPRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.18 | ||
Change | +$0.08 (+3.81%) | ||
Open | $2.11 | ||
High | $2.19 | ||
Low | $2.07 | ||
Previous Close | $2.10 | ||
Volume | 703,993 | ||
30-Day Average Volume | 1,735,778 | ||
1-Week Change | -0.46% | ||
1-Month Change | -23.51% | ||
1-Year Change | -17.42% | ||
3-Year Change | 43.42% | ||
5-Year Change | -84.80% | ||
Fundamentals | |||
Shares Outstanding | 57.9M | ||
Total Assets | $59.0M | ||
Market Cap | $126.2M | ||
Enterprise Value | $70.2M | ||
Period: QTR TTM FY | |||
Revenue | $258,000.00 | ||
Net Income | -$7.2M | ||
Free Cash Flow | $15.9M | ||
EBIT | -$7.2M | ||
EBITDA | -$7.2M | ||
Net Working Capital | $52.1M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 272 | ||
P/B | 2 | ||
P/E | -17 | ||
PEG | 0 | ||
Price/Free Cash Flow | 8 | ||
Price/Operating Cash Flow | 8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue